Overview

Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease

Status:
Completed

Trial end date:
2015-03-18

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to see whether PT20 can help people with a high level of phosphate in their blood (called Hyperphosphatemia) that are being treated with dialysis for kidney disease.

Phase:

Phase 2

Details

Lead Sponsor:

Phosphate Therapeutics

Collaborator:

Clinipace Worldwide

Treatments:

Iron